An Academic-Practice Partnership at the University of Washington School of Public Health: The Student Epidemic Action Leaders (SEAL) Team.

An Academic-Practice Partnership at the University of Washington School of Public Health: The Student Epidemic Action Leaders (SEAL) Team. Public Health Rep. 2018 Oct 09;:33354918798805 Authors: Simckes M, Melius B, Hawkins V, Lindquist S, Baseman J Abstract In 2015, the University of Washington School of Public Health, Department of Epidemiology established the Student Epidemic Action Leaders (SEAL) team to provide public health students with experience in field epidemiology in state and local public health communicable disease divisions. The University of Washington Department of Epidemiology developed the SEAL team in collaboration with the Washington State Department of Health to offer public health graduate students opportunities to contribute to the real-time needs of public health agencies during a communicable disease event and/or preparedness event. The SEAL team combines classroom and field-based training in public health practice and applied epidemiology. During the first 2 years of the SEAL team (2016-2018), 34 SEALs were placed at 4 agencies contributing more than 1300 hours of assistance on 24 public health projects. PMID: 30300568 [PubMed - as supplied by publisher]
Source: Public Health Reports - Category: International Medicine & Public Health Tags: Public Health Rep Source Type: research

Related Links:

Authors: Hanna MN, Chambers C, Punyala A, Iqbal A, Singh B, Oruc C, Prakash P, Prajapati Y, Wang Y, Amery Ai Z, Shechter R, Speed TJ, Koch CG, Williams K Abstract The use of opioid analgesics for pain management has increased dramatically over the past decade, with corresponding increases in negative sequelae including overdose and death. Physicians, policymakers, and researchers are focused on finding ways to decrease opioid use and overdose. This crisis calls for a coordinated response that includes the entire healthcare sector. In this work, the authors lay out a blueprint for such a response at the level of the...
Source: Journal of Opioid Management - Category: Addiction Tags: J Opioid Manag Source Type: research
CONCLUSIONS: Utilization of drugs that harness endogenous opioid antinociception in accordance with varying physiological states represents a novel approach for effective pain management while mitigating the present epidemic of death by synthetic opioid overdose. PMID: 32091619 [PubMed - as supplied by publisher]
Source: Journal of Opioid Management - Category: Addiction Tags: J Opioid Manag Source Type: research
PMID: 32089242 [PubMed - in process]
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
For the past month, Vir Biotechnology Inc. said it was working on ways to address the coronavirus epidemic that has killed 3,000 people since December. It made good on that promise Tuesday, inking a deal with Shanghai's WuXi Biologics. Financial terms of the development, manufacturing and commercialization collaboration centering on human monoclonal antibodies against the Covid-19 coronavirus were not disclosed by San Francisco-based Vir (NASDAQ: VIR). The deal emerges as the National Institute…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Clusters of infection are likely in American communities, health officials said. Some lawmakers questioned whether the nation is prepared.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science United States Politics and Government Coronavirus (2019-nCoV) Epidemics Respiratory Diseases Masks Centers for Disease Control and Prevention Health and Human Services Department Homeland Security Department House of Re Source Type: news
(HARTFORD, Conn.) — A coalition of 39 states will look into the marketing and sales of vaping products by Juul Labs, including whether the company targeted youths and made misleading claims about nicotine content in its devices, officials announced Tuesday. Attorneys general from Connecticut, Florida, Nevada, Oregon and Texas said they will lead the multi-state investigation into San Francisco-based Juul, which also is facing lawsuits by teenagers and others who say they became addicted to the company’s vaping products. The state officials said they also will investigate the company’s claims about the ris...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Courts onetime Vaping Source Type: news
Iran's coronavirus death toll rose to 16 on Tuesday, the highest outside China, increasing its international isolation as dozens of countries from South Korea to Italy accelerated emergency measures to curb the epidemic's global spread.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
As outbreaks grow and spread in Asia, Europe and the Middle East, U.S. officials warn Americans to brace for their own.
Source: NYT Health - Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Epidemics Travel Warnings United States Economy Stocks and Bonds New York Times Italy Iran China Source Type: news
Iraq shut schools and universities on Tuesday and told citizens to avoid mass gatherings, as it rushed to prevent the spread of the coronavirus from its neighbor Iran, hit by what appeared to be the worst outbreak outside of China.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
New Brunswick, NJ, February 25, 2020 — Johnson &Johnson (NYSE: JNJ) today announced that the Janssen Pharmaceutical Companies of Johnson &Johnson, in collaboration with Apple, opened enrollment for the Heartline™ Study. The study is designed to explore if the Heartline™ Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline™ Study, individuals must be a...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
More News: Academia | Classrooms | Department of Health | Epidemics | Epidemiology | Graduation | International Medicine & Public Health | Partnerships | Students | Training | Universities & Medical Training | University of Washington